Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06397716 · ClinicalTrials.gov registry record · NA
Public Health Initiative on Alcohol Flushing
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT06397716: Completed NA study, sponsored by Stanford University.
NCT06397716 is a NA study that has completed, run by Stanford University. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06397716, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The overall aim of the study is to raise awareness of alcohol flushing and its health risks to the general population. The primary objective is to see if spreading awareness of the health risks of alcohol flushing and understanding personalized genotype information will lead to changes in alcohol consumption behavior.
Primary Outcome
Alcohol flushing reaction awareness questionnaire, scale from 0 to 4, higher score is better outcome
Interventions
- GENETIC ALDH2 Genotyping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-04-25 |
| Est. Completion | 2024-04-25 |
| Phase | NA |
What the finished NCT06397716 record still lists
NCT06397716 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which ALDH2 Genotyping is the first listed.
NCT06397716 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06397716 about?
NCT06397716 is a clinical study titled "Public Health Initiative on Alcohol Flushing". The overall aim of the study is to raise awareness of alcohol flushing and its health risks to the general population. The primary objective is to see if spreading awareness of the health risks of alcohol flushing and understanding personalized genotype information will lead to changes in alcohol c...
What is the current status of trial NCT06397716?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2024-04-25. Estimated completion is 2024-04-25.
What interventions are being tested in trial NCT06397716?
The interventions under investigation include: ALDH2 Genotyping (GENETIC).
Who is sponsoring clinical trial NCT06397716?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06397716's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI